Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

NCT: NCT06059638 · RECRUITING

NCT IDNCT06059638
StatusRECRUITING
Start Date2023-12-27
Completion2029-08

Brief Summary

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

Frequently Asked Questions

What is BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT?

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT is a clinical trial registered under NCT06059638. Current status: RECRUITING.

What is the status of NCT06059638?

The current status of NCT06059638 (BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT) is: RECRUITING.

When did BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT start?

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT started on 2023-12-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑